Phibro Animal Health Corporation
PAHC
$47.92
-$1.67-3.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 762.14% | 280.32% | 2,190.43% | 148.42% | 150.00% |
| Total Depreciation and Amortization | 11.38% | 42.49% | 41.53% | 37.19% | 29.90% |
| Total Amortization of Deferred Charges | 13.49% | 55.86% | 17.51% | 120.00% | 93.85% |
| Total Other Non-Cash Items | -36.17% | 151.28% | 298.54% | -82.76% | 221.48% |
| Change in Net Operating Assets | -41.77% | -1,813.02% | -168.22% | 182.07% | -191.20% |
| Cash from Operations | 529.13% | -26.30% | -25.17% | 278.28% | -90.25% |
| Capital Expenditure | -41.87% | -44.07% | -0.54% | 20.40% | 28.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -2,493.18% | -8,643.99% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -115.95% | -208.34% | -80.84% | -187.38% | 460.95% |
| Cash from Investing | 93.40% | -617.20% | 22.80% | -1,715.13% | -947.72% |
| Total Debt Issued | -87.11% | -84.83% | -53.29% | 30.65% | 1,045.24% |
| Total Debt Repaid | 61.91% | 88.85% | 45.37% | -101.61% | -298.80% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.08% | -0.08% | -0.06% | -0.10% | 0.02% |
| Other Financing Activities | -- | -- | 95.00% | -258.12% | 100.00% |
| Cash from Financing | -106.87% | 155.95% | -534.58% | -763.84% | 1,979.09% |
| Foreign Exchange rate Adjustments | 87.22% | -85.32% | 269.18% | 537.96% | -69.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -213.43% | 125.19% | -62.31% | -138.95% | 249.63% |